The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; MSD; Novartis; Pfizer; Samsung Bioepis
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; MSD; Novartis; Pfizer; Samsung Bioepis
Speakers' Bureau - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; MSD; Novartis; Pfizer; Samsung Bioepis
Research Funding - Novartis
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; MSD; Novartis; Pfizer; Samsung Bioepis
Four-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2-positive early or locally advanced breast cancer in neoadjuvant setting.
 
Xavier Pivot
No Relationships to Disclose
 
Mark D. Pegram
Honoraria - AstraZeneca; Genentech/Roche; Macrogenics; Novartis; Pfizer; Samsung Bioepis; Seagen
Consulting or Advisory Role - Genentech/Roche; Macrogenics; Novartis; Pfizer; Samsung Bioepis; Seagen
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Daiichi Sankyo; Eisai; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Samsung
Consulting or Advisory Role - AstraZeneca; Athenex; Bioasis; Biothera; Celgene; Cellestia Biotech; Clovis Oncology; Daiichi Sankyo; ERYTECH Pharma; GlaxoSmithKline; Leuko; Lilly; Merck Sharp & Dohme; Merus; Polyphor; Roche; Seagen; SERVIER
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Baxalta (Inst); Bayer (Inst); Eisai (Inst); Guardant Health (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Piqur (Inst); Puma Biotechnology (Inst); Queen Mary university of London (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Eisai; Novartis; Pfizer; Roche
 
Diana Lüftner
No Relationships to Disclose
 
Hope S. Rugo
Consulting or Advisory Role - Celltrion; Ionis Pharmaceuticals
Research Funding - Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Daiichi Sankyo; Macrogenics; Merck; Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology
 
Gary H. Lyman
Consulting or Advisory Role - BeyondSpring Pharmaceuticals; bioTheranostics; Daiichi Sankyo; G1 Therapeutics; invitae; Mylan; Partners Healthcare; Samsung Bioepis; Sandoz-Novartis; Spectrum Pharmaceuticals
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Bayer
 
Giuseppe Curigliano
Honoraria - Ellipses Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Speakers' Bureau - Daiichi Sankyo; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Igor Bondarenko
No Relationships to Disclose
 
Mikhail Dvorkin
No Relationships to Disclose
 
Ye Chan Yoon
Employment - Samsung Bioepis
 
Younsoo Kim
Employment - Samsung Bioepis
 
Chul Kim
Employment - Samsung Bioepis